mRNA vaccines could vanquish COVID-19 today, cancer tomorrow
Therein lies mRNA’s bigger promise: It can tell our cells to make whatever protein we want. That includes the antigens of many other diseases besides COVID-19.
Japanese approval of Moderna COVID-19 vaccine unlikely before May
Tokyo is facing a major regulatory bottleneck due to requirements for local clinical trials before requesting approval for coronavirus shots.
Astra-Oxford coronavirus vaccine gets its first clearance with U.K. approval
AstraZeneca PLC and the University of Oxford’s Covid-19 vaccine won U.K. clearance, marking the first approval worldwide for a shot that will be key to mass immunizations.
How vaccine-makers are preparing for mutant coronavirus strains
Drugmakers have said they could reset the COVID-19 shot to counter a new strain within just six weeks.
Vaccines alone aren’t enough to beat COVID-19
While an effective vaccine is sure to help, a safe oral antiviral drug would truly step up efforts to fight the pandemic.
Moderna to seek U.S. and EU clearance for COVID-19 vaccine
The move came after a new analysis showed the vaccine was highly effective in preventing COVID-19 with no serious safety problems.
Not so fast, Japan experts say, as COVID-19 vaccines raise hopes
Medical experts say long-term safety and efficacy concerns remain as the vaccines are developed in record-setting time.
Pfizer vaccine's safety milestone is just the beginning
As new vaccines look set for regulatory approval, managing the follow-up on adverse drug reactions will be critical for any vaccination program to be successful.
Why Moderna’s vaccine win is a giant leap against pandemics
Alongside recent results from Pfizer, the news that a vaccine is proving effective is a great step forward.
A key facet of the global mad scramble by Pfizer, Moderna and other pharma groups to develop a viable coronavirus vaccine is the recruitment of tens of thousands of volunteers willing to participate in clinical trials. AFP's correspondent in Miami, Leila Macor, took part in ...
How Pfizer and BioNTech sprinted ahead in extraordinary race for a COVID-19 vaccine
Researchers were asked to tackle something that had never been done before: design a vaccine to stop a pandemic in its tracks in less than a year.
Moderna’s COVID-19 vaccine: What you need to know
Coming a week after similar news from Pfizer and BioNTech, Moderna's announcement offered more hope that there’s going to be a way out of the pandemic.
